Virtus ETF Advisers LLC Immunovant, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 3,462 shares of IMVT stock, worth $95,239. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,462

Previous 3,403 1.73%

Holding current value

$95,239

Previous $89,000 6.74%

% of portfolio

0.05%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.51 - $27.51 $1,623 - $1,623	59 Added 1.73%	3,462 $95,000
Q2 2024 Aug 14, 2024	BUY	$25.1 - $31.61 $34,437 - $43,368	1,372 Added 67.55%	3,403 $89,000
Q1 2024 May 15, 2024	SELL	$30.27 - $43.79 $4,328 - $6,261	-143 Reduced 6.58%	2,031 $65,000
Q4 2023 Feb 15, 2024	SELL	$31.31 - $44.19 $77,429 - $109,281	-2,473 Reduced 53.22%	2,174 $91,000
Q3 2023 Nov 07, 2023	SELL	$18.55 - $39.96 $8,533 - $18,381	-460 Reduced 9.01%	4,647 $178,000
Q2 2023 Aug 14, 2023	SELL	$14.2 - $23.75 $22,634 - $37,857	-1,594 Reduced 23.79%	5,107 $96,000
Q1 2023 May 15, 2023	SELL	$15.27 - $19.72 $39,320 - $50,779	-2,575 Reduced 27.76%	6,701 $103,000
Q4 2022 Feb 14, 2023	SELL	$6.59 - $17.75 $138,989 - $374,365	-21,091 Reduced 69.45%	9,276 $164,000
Q3 2022 Nov 14, 2022	BUY	$3.93 - $6.37 $868 - $1,407	221 Added 0.73%	30,367 $169,000
Q2 2022 Aug 12, 2022	BUY	$3.38 - $5.65 $30,365 - $50,759	8,984 Added 42.45%	30,146 $118,000
Q1 2022 May 16, 2022	SELL	$5.06 - $8.77 $6,441 - $11,164	-1,273 Reduced 5.67%	21,162 $117,000
Q4 2021 Feb 14, 2022	BUY	$7.33 - $9.32 $19,358 - $24,614	2,641 Added 13.34%	22,435 $191,000
Q3 2021 Nov 15, 2021	SELL	$7.01 - $11.37 $7,241 - $11,745	-1,033 Reduced 4.96%	19,794 $172,000
Q2 2021 Aug 10, 2021	BUY	$9.4 - $16.85 $138,029 - $247,425	14,684 Added 239.04%	20,827 $220,000
Q1 2021 May 17, 2021	BUY	$13.08 - $49.6 $1,504 - $5,704	115 Added 1.91%	6,143 $99,000
Q4 2020 Feb 12, 2021	BUY	$36.36 - $52.71 $219,178 - $317,735	6,028 New	6,028 $278,000

Others Institutions Holding IMVT

# of Institutions

211

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Immunovant, Inc. Transaction History